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Abstract 
Using 3D food printing with the Internet of Things (IoT) technology, patients can receive diagnoses and prescriptions from their doctors 
while in the comfort of their homes. The patient-specific prescription has been innovated by converging 3D food printing technology 
with drug delivery systems (DDSs). Quantitative drug dosages can be incorporated into the composition of food and produced in any 
shape within a short time. Automating food and DDSs makes promising implications for healing patients remotely, as well. Each of 
these aspects, along with IoT technology, have contributed to increased health care for patients, no matter their location. The 
quantitative discharge of vitamin C melted in water, mayonnaise, ketchup, and peanut butter has been verified using the Piston Typed 
Extrusion (PTE) method. Designs with different curves and shapes were repeatedly printed with a head speed of 1.6×10-2 m/s, and it 
was confirmed that effective control while printing the shapes was possible. The Hagen-Poiseuille (HP) formula was utilized to simulate 
the overall printing time. This simulation affirmed that increasing the head speed from 1.6×10-2 m/s to 4.0×10-2 m/s had reduced the 
printing time consistently, but the time was not reduced continuously after 4.0×10-2 m/s, depending on the materials’ viscosities  
and how much curvature exists in the designs. The precision of printing was adjusted within 5% of the theoretical value during printing, 
and the IoT technology allowed printing of the materials within five minutes, regardless of the patient’s location. 
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Introduction 
The historical Greek physician Hippocrates said no medicine is 
needed since there is no illness that cannot be cured with 
food.1 In the modern age, the advantages of food and medicine 
have been placed hand-in-hand for the benefit of humanity. A 
revolutionary drug delivery system (DDS) that accurately 
controls the dosages of drugs within food’s composition has 
been studied. The development of a DDS to transmit precise 
amounts of drugs remotely has been a long-term interest in 
the medical field. DDSs have focused on a continuous delivery 
mechanism within the body by the use of microstructures in 
materials, and this field has been researched.2,3,4 One example 
of these mechanisms is the Ringer’s solution. As the most 
preferred technique for drug transmissions, a Ringer’s solution 
is given to people who feel fatigued. All of the solutions appear 
transparent, but there are hundreds of species, depending on 
its purpose. Basic solutions are prescribed to replenish the 
water levels of patients whose electrolytes are not balanced 
due to possible difficulties in drinking water or abnormalities 
in their heart or kidneys. Nutritional solutions are mixtures of 
solutions. Proteins, carbohydrates, fats, vitamins, and trace 
elements can be supplemented through these solutions.  
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Special solutions are used for particular medical situations.5  
In cases of blood infusions, precise amounts of dosages can be 
administered to a patient, depending on their age, weight, and 
clinical or biological conditions.6 These scenarios include 
administering a solution that lowers the pressure being placed 
on a patient's brain due to cerebral hemorrhaging and 
dispensing a solution to keep the amount of blood flow 
constant.  
 
The technique of making  the solutions has contributed to the 
development of macro-DDSs by shining light on how versatile 
DDSs can become. This versatility has been achieved with basic 
solutions, nutritional solutions, and special solutions, but the 
process of making these solutions is not easy, and many errors 
can occur.5  It carries the risk of underdosing or overdosing 
patients, and medical doctors or nurses are incapable of being 
ever present to monitor each patient for these risk factors. The 
equipment involved in this method can be cumbersome.6 
When a macro-DDS is applied, the solutions can be accurately 
delivered to the patient from remote locations, and 
customized medication can be created for each patient using 
the Internet of Things (IoT) technology.7 The new field of 
macro-DDSs will span beyond the confines of micro-DDSs using 
IoT-based technology. This novel application has the potential 
to be directly involved in disaster situations or in health care 
to deal with daily food management for consumers without 
space constraints. Future DDSs are based on this recent 
concept as it can be utilized in transferring precise amounts of 
drugs without space constraints, mixing viscous substances, 
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solidifying a fluid for consumption when a patient may not be 
able to ingest liquids, and using equipment that quantifies the 
liquid state of a solution onto the surface of solidified food. 
Implementation of macro-DDS will lead to a new health 
technique for quantitative medicinal management. 
 
Production of quantified medication by this unique 
pharmaceutical system requires 3D printing technology for 
real practice. The applicability of 3D printing technology in the 
medical field has already been extensively explored. One 
instance is that of the research conducted on microneedle 
patches.8 Microneedle patches are dime-sized plastic strips 
that contain tens to hundreds of drug-filled microscopic 
needles. These needles are soluble in water, and little to no 
pain is felt when applied to a patient’s skin.9 Another example 
of 3D printing in the medical field is the use of UV light to 
manufacture drug-containing structures by crosslinking. These 
structures, with different pore sizes and different drug 
loadings, were able to control drug release rates using 3D 
printing technology.10 
What each of these medical devices have in common is that 
they are produced using 3D printing technology. Challenges 
dealing with space, time, and shapes remain with these 
innovative DDSs. Effective drug delivery must not only be 
quantitatively controlled, but also must be free from space 
constraints, delivered in a short time, and printed with patient-
preferred shapes in order to be easily accessed by the patients. 
The authors of this study have submitted a patent on this DDS, 
and it is currently being utilized for pharmaceutical trainings 
and education.11 The trainees have succeeded in simulating 3D 
printing with the quantitative ejection of nutrients and 
carbohydrates into food.12 This research is encouraging since 
it shows that, if high viscosity food material can be quantifiably 
printed, high viscosity drug solutions can be as well. This 
technology has been continuously tested since 2018 in the 
joint degree program between The College of Engineering and 
The School of Pharmacy.12 
Advancements in 3D printing technology enabled custom 
applications to produce personalized drug treatments for 
individuals via the use of both the Cloud and robotic 
technologies.13,14 For innovative DDS to be practical,  space 
constraints must be overcome through the IoT technology 
system. To illustrate the IoT process, it can be divided into four 
sections: the Cloud, where information is accessed; MongoDB, 
the database where information is stored; Raspberry Pi (RP), 
the microprocessor of the system; and Arduino, the 
microcontroller of the printer. The cloud displays printing 
conditions, printing designs, user data, locations, and codes for 
available printers in a database called MongoDB.15 When a 
printer or a user requests any data, the stored data from 
MongoDB is transferred to the RP. The RP of the printer 
receives the data and orders the Arduino board to control the 
movement of the printer head according to its printing 
conditions and design. RP microprocessing equipment, with an 
Arduino microcontroller, has been patented.7 A patient’s 
health information is entered through a smartphone device. 
Then, this data is stored and analyzed by MongoDB in the 
Cloud. This data can be recalled to smartphone devices at any 
time. MongoDB calculates food printing conditions based on 
the analyzed data. The user selects the design and requests for 
it to be printed. Next, the saved G-code file is transferred to 
the RP of the printer. When an RP sends orders to an Arduino 
board, printing begins to produce food that fits the health 
conditions of patients. Because all the data is stored in the 
cloud, it can be retrieved and printed from anywhere 
whenever the device and printer are connected to the Wi-Fi. 
By finding practical ranges with real-time analysis of weight, 
head movement, temperature, etc, the optimal printing 
conditions have been thoroughly examined. First, data was 
sent to the Cloud from the RP. Next, the data was analyzed and 
sent back to the RP board from the Cloud server. These signals 
were transmitted from the RP to an Arduino board to initiate 
the printing operation.16 Applications on the Cloud can access 
microcontroller-based devices and collect data from them. 
This is what is meant by the term Internet of Things.16 The “IoT-
enabled 3D Food Printer” had been successfully used by 
pharmacists, patients, and their family members through the 
food control program of the pharmacy.7,12 
With IoT technology, being able to 3D print drugs onto food 
from a distance with accurately customized ingredients can be 
achieved. By incorporating protein sources, healthier diet 
options for patients who have certain restrictions on what they 
can consume can be created.17 Specialists can properly 
prescribe what the patients or elderly would need based on 
previously gathered data from a remote location. Specialists 
can also determine which foods or nutrients need to be added 
to patients’ diets by using high viscosity material extrusion 
technology. The assistants attending to the patients or elderly 
can use their smart devices to have the patient’s food printed, 
or get the food or drugs sent to the patient right when they are 
ready without the patient having to prepare anything else. 
After the prescription is given to the patient and feedback is 
received from them, IoT technology can store the data and 
analyze the exact amount of each ingredient or drug that 
needs to be prescribed next time. Accumulation of 
prescription data and printed conditions will decrease more 
and more errors during printing or drug delivery with respect 
to time. 
 
Removing space constraints is essential in ensuring that 
patients globally can receive adequate healthcare using IoT 
technology. The IoT technology allowed DDSs to become 
remote and adaptable to different situations. Automating food 
and DDSs for disaster relief efforts is a possible 
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implementation of this technology, since raw ingredients can 
be shipped to remote areas easily. This means, as machines 
handle the preparation of food, medical responders can focus 
on treating the injured or ill. Infrastructure for monitoring 
consumers’ medical data can also be established, allowing the 
assessment of changes in health conditions in real-time. These 
features, in combination with IoT technology, will be essential 
in improving patients’ health. 
 
The applicability of IoT technology has previously been 
demonstrated through preliminary testing. Using twenty 
donated 3D printers in cooperation with a company based in 
South Korea, the research team at The University of Texas at 
El Paso (UTEP) achieved in video conferencing employees of 
the company while simultaneously having products 3D printed 
at the company using IoT based 3D printers. Represented in 
Fig. 1 is the conceptual diagram of IoT technology being 
employed. In this study, remote printing was successfully 
conducted by sending a design file from the Engineering 
building at UTEP to The School of Pharmacy located 1.61 km 
away with a smartphone. 
 
 
 
Figure 1. Conceptual diagram of using IoT.  
 
 
The study aimed to improve the potential of quantitative drug 
delivery by 3D printing with food and changing the delivered 
drug amounts based on the printed design or shape. Using 3D 
printing techniques rather than ordinary ingestion or injection 
of the drug is expected to reduce the errors of drug delivery. 
The 3D printer's capability to control the flow rate or printing  
speed can allow quantitative drug control on any design or 
shape.18 In order to confirm this hypothesis, the optimization of 
time and accuracy of 3D printing drugs with food, the 
quantitative discharge of the material, and evaluation of the 
potential of the new DDS in conjunction with the IoT system has 
been observed.  
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Experimental Methods 
Equipment 
The PTE method allowed the quantitative printing of highly 
viscous food material or biomaterial.16,19-22 The designs of the 
developed IoT-enabled equipment were patented and used for 
testing in this research.7,23,24 
Using the printers, medication was printed into food products 
or onto the food’s surface. The combination of the food and 
medical industries has allowed the customization of food with 
specific amounts of ingredients and drug dosages for patients 
in the manner that was previously described.  
 
 
 
Figure 2. The IoT-enabled 3D printer.24 
 
 
 
Materials 
In the experiment, water, mayonnaise, ketchup, and peanut 
butter, which are all highly viscous victuals, were used to verify 
that the needed components were dissolved in a solution and 
that the composition was controlled. Any nutrients and their 
compositions can be controlled and placed in a variety of highly 
viscous liquids in the form of a Ringer’s solution, allowing 
patients to receive more accurate amounts of nutrients from 
remote locations. Represented in Table 1 is the viscosity, 
density, pressure, and flux of each of the used materials. 
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Table 1. Conditions of used materials extruded using a tip-diameter of 1.66× 10-3 m and tip-length of 2.30× 10-2 m.   
Materials Viscosity (Pa·s) Density (g/m
3) Pressure (MPa) Flux: qw×10
2  
(g/s) 
Water (10wt.% medicine) 0.001-10* 1.10×106 0.101 3.74 ± 0.23 
Mayonnaise* (10wt.% medicine) 5-100* 1.03×106 0.123 3.77 ± 0.28 
Ketchup* (10wt.% medicine) 75-100 9.03×105 0.432 3.60 ± 0.22 
Peanut Butter* (10wt.% medicine) 250-1000 1.06×106 1.205 3.53 ± 0.33 
    *Viscosity of material varies with temperature and compositions 
 
 
Quantitative Control 
The most important feature of IoT-enabled 3D printing for 
patients in the medical field is quantitative control of the 
material when being discharged. Since any minimal changes in 
the amount or composition of drugs or food may worsen 
diseases or cause severe side effects for patients and the 
elderly, IoT technology will contribute significantly in easing 
symptoms and reducing side effects. This technology features 
scales that allow operators to control and verify how much of a 
material is discharged during printing. To ensure the 
applicability of this technology in a Ringer’s solution, a supply 
of medical salt water had been discharged within the solution. 
Whereas the injection error range in a typical injection method 
is between 5 and 10 ml based on 150 ml, salt water was 
experimented with to find the range or pressure signal where 
the more accurate injection was possible. The experiment was 
conducted by injecting salt water into distilled water, then 
injecting various materials repeatedly within the solution.  
Time and Accuracy with Shape of Printing  
Drugs manufactured using IoT technology in the field should be 
delivered to the patients as soon as possible. A certain amount 
of medicine must be printed within three minutes and 
accurately delivered to where it is needed. Designs with 
different curves and shapes were printed with a head speed of 
1.6×10-2 m/s, and a vitamin C composition of 10 wt.% was 
melted in ketchup. The experiment was repeated to effectively 
print the entire drug by controlling the high curvature and size 
of the shapes using different designs. The theoretical error 
range and accuracy of printing was obtained by calculating the 
difference in volume between each discharged print. 
Printing Stability in Relation to Head Traveling Speed 
The stability of the printed shape, with respect to increasing 
head speed, was observed. Since drugs produced using IoT 
technology must be delivered in a short time, an attempt was 
made to print a certain amount of a drug within 10 minutes, 
then accurately deliver it. For this purpose, how accurately the 
different shapes were printed with the slowest speed of 2.0×10-
2 m/s needed to be known. When printing the various shapes, 
ketchup and mayonnaise were used as ingredients with vitamin 
C incorporated into them. The HP formula was also utilized to 
simulate the overall printing time. This assisted in reducing the 
printing time by increasing the head traveling speed and 
predicting the accuracy and stability of discharge of the 
materials.  
Results and Discussion 
Time and Accuracy with Shape of Printing  
In the case of printing vitamin C into the ketchup with a head 
speed of 1.6×10-2 m/s; it was confirmed that the vitamin was 
evenly distributed within 1.8% from the target position, 
regardless of the shape used. Provided in Table 2 below are the 
printed shapes, and the absolute amounts of vitamin C added 
to them by experimenting with the given shapes repeatedly 
with the head speed of 1.6×10-2 m/s. The PTE method was used, 
along with a tip diameter of 1.6×10 -3 m.  Depending on the 
shape shown in the table below, it was found that 101.5 mg to 
376.4 mg of the vitamin was printed, which took between 27.5 
seconds to 102 seconds to print. 
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Table 2. Time consumption and vitamin C loaded capacity in each printed design. 
The line of printing time by total weight indicated that all of the materials were quantitatively 
 discharged for 300 seconds using a tip-diameter 1.5×10-3 m and tip-length 1.80×10-2 m. 
Design Time Consumption (s) Vitamin C (mg) 
 
      a) Skull 
 
102.0 376.4 ± 6.9 
b) Monster 
 
27.5 101.5 ± 1.9 
       c) Rose 
 
80.0 295.2 ± 5.4 
       d) Fox 
 
33.1 122.1 ± 2.2 
      e) Rabbit 
 
45.0 166.1 ± 3.0 
      f) Snail 
 
82.6 304.8 ± 5.6 
     g) Horse 
 
58.8 217.0 ± 4.0 
     h) UTEP Logo 
 
60.0 221.4 ± 4.1 
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Time Savings 
An effect of increasing the head speed on the printing time and 
the stability of the printed shape was observed. Shown in Fig. 3 
are the times taken to print each of the shapes by increasing 
the head speed relative to the time taken at 2.0×10-2 m/s. Each 
shape’s time varied depending on its curvatures and angular 
parts. These shapes were printed by increasing the head speed 
from 2.0×10-2 m/s, which takes about 30 minutes, to confirm 
the point of highest stability in the figure where quantitative 
discharge was possible. It was confirmed that any shape could 
be stably printed in the range of 4.0×10-2 m/s to 4.8×10-2 m/s. In 
the case of complex shapes, increasing the head speed over 
6.0×10-2 m/s did not reduce the time needed. As the curvatures 
or bending in the shape increases, so does the amount of time 
needed to print it. 
 
Time Reduction and Accuracy by Head Traveling Speed 
By incrementally increasing the head’s speed by 0.8×10-2 m/s 
from 1.6×10-2 m/s, regardless of the printed shape, the time 
taken to complete each print was divided by the printing time 
at the head speed of 1.6×10-2 m/s. This value is described as the 
Printing Time Ratio in the figure below. If the head speed is 
increased by a factor of two, the Printing Time Ratio should be 
halved. The reduction of time, according to the HP formula, is 
represented by a dotted line and labeled as the Ideal Case. It 
was confirmed through the simulation that increasing the head 
speed does not reduce the printing time continuously, 
depending on different viscosities of materials and how much 
bending is prevalent in the designs. The simulation results 
confirmed that, if the head speed was increased from 1.6×10-2 
m/s to 4.0×10-2 m/s, the printing times did not deviate 
significantly from the theoretical value, regardless of the shape. 
It was shown from the printing simulation below that the time 
required for actual printing was not significantly reduced, unlike 
the theoretical prediction. This depended on stopping of the 
material, bending, changes of direction, etc. 
 
 
Figure 3. Printing time in relation to printing head speed by design and shape of the eight models. 
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As shown in the results in Fig. 4 and Fig. 5, the head speed  was 
increased by intervals of 0.08 m/s from 1.6×10 -2 m/s to 4.0×10 
-2 m/s while producing a penguin design. As a result of printing 
the shape repeatedly, the total discharge with increasing head 
speed was 1.80 ± 0.05 g and the accuracy percentage was 
2.96%, in the case of ketchup. For the mayonnaise with vitamin 
C added, the total discharge was 1.49 ± 0.06 g with 4.22% 
accuracy. 
 
 
Ketchup w/ 10wt% 
Vitamin C 
 
Head Traveling Speed 
(m/s) 
1.6×10 -2 2.4×10 -2 3.2×10 -2 4.0×10 -2 
Time Consumption (s) 47 32 24 20 
Flux (g/s) × 10-2 3.69 ± 0.07 5.69 ± 0.15 7.50 ± 0.21 9.12 ± 0.06 
Total Weight (g) 1.80 ± 0.05 
Figure 4. Printing time reduction and accuracy by printing speed with vitamin C  
loaded ketchup using a tip-diameter of 1.5× 10-3 m and tip-length of 1.80× 10-2 m. 
 
As shown in Fig.4 and Fig. 5, when the head speed was 4.0×10-
2 m/s, the discharge strength outrunning the friction between 
the material and the piston tip was constant. The error range 
was 0.68% for ketchup and 2.6% for mayonnaise, which were 
lower than that of the average error range. As presented in Fig. 
4 and Fig. 5, the stability of the shape was low when it was 
printed using a head speed of 4.0×10-2 m/s. The surfaces of the 
printed materials were not smooth, showing incomplete shapes 
compared to other head speed conditions. The roughness on 
the surface aggravated as the shape became more complicated.  
 
 
Mayonnaise w/ 10wt% 
Vitamin C 
 
Head Traveling Speed 
(m/s) 
1.6×10 -2 2.4×10 -2 3.2×10 -2 4.0×10 -2 
Time Consumption (s) 47 32 24 20 
Flux (g/s) × 10-2 3.11 ± 0.15 4.59 ± 0.26 6.24 ± 0.26 7.70 ± 0.20 
Total Weight (g) 1.49 ± 0.06 
Figure 5. Printing time reduction and accuracy by printing speed with vitamin C 
 loaded mayonnaise using a tip-diameter of 1.5× 10-3 m and tip-length of 1.80× 10-2 m. 
 
Original Research PRACTICE-BASED RESEARCH 
 
http://z.umn.edu/INNOVATIONS                         2018, Vol. 9, No. 3, Article 11                        INNOVATIONS in pharmacy 
                                                                             DOI: https://doi.org/10.24926/iip.v9i3.1450 
9 
 
Quantitative Discharge with Respect to Time 
Provided in Fig. 6 below are the analyzed weights of the printed 
designs, according to the printing time. Using the PTE method, 
(a) water, (b) mayonnaise, (c) ketchup, and (d) peanut butter 
were printed with 500 mg of the drug once it was melted. As 
displayed in the graph of Fig. 4, the proportional line of the 
printing time by the total weight indicated that all of the 
materials were quantitatively discharged for 300 seconds. In 
order to decrease the change in pressure (∆P) and optimize the 
extrusion, a tip-diameter of 1.66× 10-3 m and tip-length of 2.30× 
10-2 m was used. 10wt.% of vitamin C was included in the food 
material, lowering its viscosity. This has increased ∆P within the 
piston, increased the flux of the materials (qw), and increased 
its total discharge weight for all experiments from the expected 
or theoretical value.  
 
 
 
 
Figure 6. Measured weight of each printed design using (a) water, 
 (b) mayonnaise, (c) ketchup, and (d) peanut butter printed with 10 wt.% of the drug. 
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As confirmed by the previous experiment, where the results are 
shown in Fig. 6, quantitative control of the materials during 
discharge was attained. The outcome of the research is 
promising since it manifests future uses in controlling the exact 
amount of any nutrient varying from carbohydrates to fats and 
medication, allowing for the customization of patients’ diets. As 
displayed in Fig. 7, the patients are capable of adding or 
removing their prescribed medications or nutrients from their 
preference of food. Previous DDSs have been based on 
targeting and control methods that are not regularly attainable 
for patients unless they are present at a medical facility.25-27 
Rather than reusing these standard DDS methods, controlling 
the composition of the food and medication, as shown below, 
will result in increased accessibility for patients who have 
difficulties with mobility. 
 
 
 
Figure 7. Controlled printing of the nutrients or medication incorporated into different food products. 
 
 
Patient-specific Drugs 
For many medications, drug intake is highly recommended 
during meals, 30 minutes after meals, or immediately after 
meals. In the case of those living with diabetes, patients must 
intake the drugs within 30 minutes after a meal for the drugs to 
be effective. However, there is the problem of the elderly or 
children forgetting to take their prescribed medication, which 
can cause side effects or symptoms to intensify. 
Making medication in the form of liquid solutions and pills 
enabled elderly and ill patients to effectively intake drugs by 
mixing them with ordinary food. Exhibited in Fig. 8 are printed 
products with various shapes and materials. This showed that 
the drugs can be printed in any form or shape on the food. 
Assuming that 500 to 1000 mg of Metformin HCl was ingested, 
if the solution was produced with a high viscosity material by 
dispersing it in an aqueous solution, the addition of chemicals, 
water, and other solids would allow the adjustability of the drug 
content to 10 wt.% of the fluid. The patient may intake a 10 wt%  
Metformin slurry in water 5 to 10 g at a time. It was confirmed 
that the drug can be delivered in various shapes by printing less 
than 10 g onto food, such as semi-solid water, mayonnaise, 
ketchup, jam, and peanut butter. 
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Figure 8. 3D printed designs using IoT technology with various drug-loaded materials utilizing a tip-diameter of 1.66× 10-3 m and 
tip-length of 2.30× 10-2 m. a)-b) peanut butter; c)- f) ketchup; g) yogurt; h) ketchup; i) chocolate pudding. 
 
When IoT technology is utilized, real-time data will be analyzed 
and used to identify the points where the shape can collapse, 
depending on the design or printing head speed. Then, the 
material can be discharged from the points where the shape 
will not collapse. This allows the patients to eat 3D printed food 
that will not subside in a short time.   
By analyzing printing materials in real-time, each material can 
be stably printed in any design. This was possible by the 
optimization of the printing head speed, according to the type 
of material, viscosity, and number of bends in the design. As 
shown in Fig. 8, the prints of a design with various materials 
were stable every time without collapsing or spillage, even 
though each design was printed three times. It is noteworthy 
that a patient can choose any food material that is loaded with 
drugs and print the designs without any collapse in the figures 
or unappealing shapes. The real-time analysis using IoT 
technology will allow the detection of any substance that was 
lost or overflowed during printing, giving specialists the 
capability of precisely determining the next prescription for the 
patient. 
The potential for the IoT system to be applicable for patient-
specific drugs is not only limited to real-time analysis of the 
design or printing status, but can also be utilized to monitor 
environmental conditions for material storage within the 
printer. This will allow the printer’s systems to compensate for 
these factors and keep the material at optimal conditions for 
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use when it is needed. As all medications have different 
prescription labels and handling guidelines, the medications 
that cannot be stored in large quantities outside of medical 
facilities or that need special containment will still need to be 
stored differently based on specialists’ instructions or will need 
to be held at medical facilities. 
The limitations that were observed for this experiment dealt 
with the constraints placed on the storage of the materials 
within the printers and with the security of individuals’ data. 
The depletion of drugs or food material would need nurses or 
medical assistants to replenish the lost material in order for 
patients to continue receiving adequate care within their 
homes. In addition, the sensitive health data of patients’ needs 
to be kept confidential and protected from potentially 
fraudulent activity. Future studies will present solutions to 
these limitations by examining procedures to sustain the levels 
of materials within remote 3D printers and by conducting 
research on methods to develop the security systems of the IoT 
database.  
Conclusion 
The revolutionary patient-specific prescription has been 
successfully verified by converging 3D food printing technology 
with DDSs. Quantitative dosages of drugs were incorporated in 
the composition of various foods. Vitamin C and other food 
ingredients were precisely printed within 5% of the theoretical 
target during printing within five minutes. The prints could be 
created using various figures, regardless of the design or 
distance from where the print was ordered to where it was 
produced. The application of the IoT-enabled 3D printer makes 
it possible to heal patients of their diseases given time and the 
correct nutritional plans for patients requiring an effective DDS. 
Consumers' daily use of the IoT system is a realistic 
implementation that will allow them to print their personalized 
meals. Ordinary users can customize any victual product with 
their choice of ingredients and shapes and have it produced in 
minutes. The customers can remove specific ingredients that 
they are allergic to or add the ones they prefer with accurate 
amounts. The IoT technology will also monitor for changes in 
mood, appetite, health, and many other factors in real-time. 
This means both patients and day-to-day customers can video 
conference with a doctor who can diagnose their conditions 
and prescribe dosages of medication and food for them to 
intake. Exchange of messages or gifts using AM technology is 
applicable by representing special and unique shapes or images 
on the food. These claims have yet to be seen until now due to 
the emergence of IoT 3D printing, and the possible applications 
of this technology are copious. A better understanding of how 
this process would work and a step-by-step application from 
the medical field’s perspective of DDSs will lead the way to real 
innovation. 
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